Senhwa Announces First Patient Successfully Dosed in Phase I Study of Pindnarulex in Combination with Pfizer's Talazoparib for the Treatment
Nov 1, 2022 ·
1m 53s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Information
| Author | Nektar Group Podcast |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
